Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Barbie

Showing results (31-40 of 120) with videos related to

Pageof 12
Sort By:
Cells|November 26, 2022
Distinct Dynamics of Migratory Response to PD-1 and CTLA-4 Blockade Reveals New Mechanistic Insights for Potential T-Cell Reinvigoration following Immune Checkpoint BlockadeFateme Safaeifard, Bahram Goliaei, Amir R Aref, et al.
Small Methods|April 4, 2022
A Robust Method for Perfusable Microvascular Network Formation In VitroZhengpeng Wan, Amy X Zhong, Shun Zhang, et al.
Molecular Cell|December 20, 2024
RNA sensing induced by chromosome missegregation augments anti-tumor immunityNobunari Sasaki, Mizuki Homme, Takahiko Murayama, et al.
Cancer Immunology Research|September 20, 2023
EDIL3 as an Angiogenic Target of Immune Exclusion Following Checkpoint BlockadeSaba Tabasum, Dinesh Thapa, Anita Giobbie-Hurder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 6, 2026
Presenting features and outcomes to standard systemic therapies in patients with MTAP-deleted advanced non-small cell lung cancerJulian Huang, Mihaela Aldea, Kathryn W Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2024
Phase I/II Investigator-Initiated Study of Olaparib and Temozolomide in SCLC: Final Analysis and CNS OutcomesCatherine B Meador, Subba R Digumarthy, Beow Y Yeap, et al.
Nature Communications|April 13, 2023
Priming a vascular-selective cytokine response permits CD8<sup>+</sup> T-cell entry into tumorsDae Joong Kim, Swetha Anandh, Jamie L Null, et al.
Cancer Research|October 31, 2019
Phosphorylation of RAB7 by TBK1/IKKε Regulates Innate Immune Signaling in Triple-Negative Breast CancerJessica L Ritter, Zehua Zhu, Tran C Thai, et al.
Biomaterials|July 24, 2021
A robust vasculogenic microfluidic model using human immortalized endothelial cells and Thy1 positive fibroblastsZhengpeng Wan, Shun Zhang, Amy X Zhong, et al.
Materials Today. Bio|June 15, 2026
Polyelectrolyte nanoparticles enable intracellular delivery of STING protein fragments for ovarian cancer immunotherapyJustin A Kaskow, Altaf Bacchus, Victoria F Gomerdinger, et al.
Pageof 12

Showing results (31-40 of 120) with videos related to

Sort By:
Pageof 12
Cells|November 26, 2022
Distinct Dynamics of Migratory Response to PD-1 and CTLA-4 Blockade Reveals New Mechanistic Insights for Potential T-Cell Reinvigoration following Immune Checkpoint BlockadeFateme Safaeifard, Bahram Goliaei, Amir R Aref, et al.
Small Methods|April 4, 2022
A Robust Method for Perfusable Microvascular Network Formation In VitroZhengpeng Wan, Amy X Zhong, Shun Zhang, et al.
Molecular Cell|December 20, 2024
RNA sensing induced by chromosome missegregation augments anti-tumor immunityNobunari Sasaki, Mizuki Homme, Takahiko Murayama, et al.
Cancer Immunology Research|September 20, 2023
EDIL3 as an Angiogenic Target of Immune Exclusion Following Checkpoint BlockadeSaba Tabasum, Dinesh Thapa, Anita Giobbie-Hurder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 6, 2026
Presenting features and outcomes to standard systemic therapies in patients with MTAP-deleted advanced non-small cell lung cancerJulian Huang, Mihaela Aldea, Kathryn W Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2024
Phase I/II Investigator-Initiated Study of Olaparib and Temozolomide in SCLC: Final Analysis and CNS OutcomesCatherine B Meador, Subba R Digumarthy, Beow Y Yeap, et al.
Nature Communications|April 13, 2023
Priming a vascular-selective cytokine response permits CD8<sup>+</sup> T-cell entry into tumorsDae Joong Kim, Swetha Anandh, Jamie L Null, et al.
Cancer Research|October 31, 2019
Phosphorylation of RAB7 by TBK1/IKKε Regulates Innate Immune Signaling in Triple-Negative Breast CancerJessica L Ritter, Zehua Zhu, Tran C Thai, et al.
Biomaterials|July 24, 2021
A robust vasculogenic microfluidic model using human immortalized endothelial cells and Thy1 positive fibroblastsZhengpeng Wan, Shun Zhang, Amy X Zhong, et al.
Materials Today. Bio|June 15, 2026
Polyelectrolyte nanoparticles enable intracellular delivery of STING protein fragments for ovarian cancer immunotherapyJustin A Kaskow, Altaf Bacchus, Victoria F Gomerdinger, et al.
Pageof 12